Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings

Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings

Researchers aimed to shine light on this key topic, tracking data from nearly 200,000 patients. 

June 2, 2022
contrast shortage

Contrast shortage update: GE expects supply to 'progressively recover' soon

Production at the facility in Shanghai is expected to be near 100% starting on June 6.

June 2, 2022
Abbott’s FreeStyle Libre 3 glucose monitor gains FDA clearance

Regulatory Roundup: FDA clears 2 new devices, grants breakthrough designation to advanced AI model

Catch up on several recent FDA announcements, including an update on the agency's response to the COVID-19 pandemic. 

June 1, 2022
Iodine contrast being loaded into a contrast injector in preparation for a cardiac CT scan at Duly Health and Care in Lisle, Illinois. The contrast shortage is causing some healthcare organizations to postpone exams and procedures and ration contrast supplies. Photo by Dave Fornell

ACR working with FDA and HHS to help address imaging contrast shortage

The American College of Radiology (ACR) announced this week its government relations staff has been engaging federal agencies in an effort to improve product availability and hasten resolution of the ongoing iodine contrast shortage.

May 26, 2022
Cardiac CT imaging has been moved to the forefront of medical imaging to evaluate chest pain under the new 2021 chest pain guidelines from the AHA and ACC. #Yescct #CCTA #CTA #CT

VIDEO: The new role of cardiac CT under the 2021 chest pain evaluation guidelines

Eric Williamson, MD, president of the Society of Cardiovascular Computed Tomography (SCCT) and professor of radiology at Mayo Clinic, explains the rapid rise of interest in cardiac CT imaging following its inclusion as a top recommendation in the ACC 2021 Chest Pain Evaluation Guidelines.

May 24, 2022
A comparison between a traditional iodine contrast angiogram (left), and a gadolinium contrast angiogram (right). MRI gadolinium contrast is starting to be used in some interventional radiology procedures and is being considered in interventional cardiology due to the iodine contrast shortage.

Gadolinium can be used as substitute for iodine contrast in some interventional imaging procedures

Gadolinium might be an alternative, stop-gap solution for interventional procedures during the current iodine contrast shortage.

May 23, 2022
The imaging iodine contrast shortage is delaying procedures and causing rationing at hospitals. impact is it having on hospitals and the tough decisions that are being made to triage patients to determine if they will get a contrast CT scan or an interventional or surgical procedure requiring contrast. Photo by Dave Fornell

VIDEO: Imaging contrast shortage is delaying procedures and causing rationing

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the American College of Radiology Board of Chancellors, explains the contrast shortage situation and the tough decisions providers are being forced to make.

May 23, 2022
Kirk Garratt, past SCAI president, explains the impact of the iodine contrast shortage on interventional cardiology and the cath lab. #SCAI

VIDEO: How the iodine contrast shortage is impacting interventional cath labs

Kirk Garratt, MD, medical director of the Center for Heart and Vascular Health, ChristianaCare, and a past president of SCAI, explains what this shortage means for interventional cardiologists.

May 19, 2022

Around the web

The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible. 

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.

Trimed Popup
Trimed Popup